Type I interferonIRF7 axis instigates chemotherapyinduced immunological dormancy in breast cancer

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

20:32 EST 13 Dec 2018 | Nature Publishing

More From BioPortfolio on "Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer"